1. British pharmacopoeia. (2022).The stationary office, London, Vol II 240–243.
2. Moharana, A.K., Banerjee, M. and Sahoo, N.K.(2011). Development and validation of visible spectroscopic method for the determination of mesalamine in bulk and tablet formulation. Asian Journal of Research in Chemistry. 4, 647–649
3. Katzung, B.G. masters, S.B. and Trevor, A.J.(2022). Basic and Clinical Pharmacology, MG-Graw,-Hill companies, Inc. United States, 12thedition 1106–1108.
4. Zaranappa, N.K.P.C., C.K and D.(2016).Spectrophotometric and Chromatographic Methods for the Estimation of Mesalamine :A BRIEF REVIEW, Journal of Pharma Research. 5(8), 199–201
5. Determination of Mesalamine Related Impurities from Drug Product by Reversed Phase Validated UPLC Method